Member Info for BuenaVista

Nah. AVA3996 was the clincher. The D-Ala-L-Pro dipeptide specificity for FAPα was then proven invitro and in animals.

^Paul Ehrlich

Alternative view: idiots didn't realise when it was explained to them that Avacta's targetted cytotoxins are the 'Holy Grail' of cancer treatment - Paul Ehring's 'Magic bullets'.

Thank you for the explanation. I've gotta say, immunology is more complex than rocket science to me, and I don't understand rocket science!

Thank you for your responses.

What is it that makes HEMO-CAR-T a 3rd(?) generation CAR-T?

You've hit a deep vein there eggy

Well strictly multi means more than one but I guess everyone has their own definition/threshold. For me it would be 3 or more. And of course it depends what one's average cost is. I'd be very happy with 4x the current share price - a multibagger, but would obviously prefer 10x or more so that I never had to think about my pension. It just requires patience. Or as Alderbaron would say, patients.

How do you define 'multi bag'?

I take it that the 'safety switch' is a major part of Hemogenyx's USP? Could someone please explain what it is and how it works, and what advantage it offers over competitors?

I once went on a Laboratory of the Government Chemist residential course in chemical nomenclature up in Lytham St Annes. It was an enjoyable three days but I flew back more confused than when I'd arrived.

Comprehension isn't your strong skill is it.

73.01 wyn. I am a convert to RSI. A lot easier - the work is done for me - and less messy than crayons and a book of spells. A retrace to 64.5p would suit me fine (have a limit order in for 65p), although happy to hold a bit of cash in reserve for Avacta or another share or a fund or just as cash.

It was a question I posed during Tuesday's IMC webinar but, as ever, it wasn't put to management because it wasn't submitted and selected by management prior to the webinar so there wasn't a preprepared answer.

Anti-fibrogenics

"Does it have to be a chemo warhead targetting FAP"

That is the question Bella. Have they made produgs of anti-inflammatories and/or anti-fibrongenics and tested them in animal models? We won't know unless and until they sign partnership deals for those indications.

I'd be getting the pom-poms out if it were not for remembering your earlier prediction of 65p by Wednesday that led to a retrace back to 50p.

Defiantly needs to throw in the kitchen sink. Goffer it!

Now's an excellent time to double your short then. Good luck treasure!

Sorry, for that 5 minute time slot. Now about 2.165m

Just before or around 12:10.

May be the volume for that minute, but even so...

https://uk.investing.com/equities/avacta-group-plc-chart